Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 04:00PM ET
16.60
Dollar change
+0.12
Percentage change
0.73
%
IndexRUT P/E75.28 EPS (ttm)0.22 Insider Own10.84% Shs Outstand151.42M Perf Week-7.57%
Market Cap2.57B Forward P/E28.02 EPS next Y0.59 Insider Trans-0.55% Shs Float137.79M Perf Month17.73%
Income41.20M PEG- EPS next Q-0.04 Inst Own57.61% Short Float27.47% Perf Quarter27.50%
Sales289.33M P/S8.87 EPS this Y-138.27% Inst Trans-5.76% Short Ratio10.13 Perf Half Y37.53%
Book/sh1.04 P/B16.03 EPS next Y1820.18% ROA14.44% Short Interest37.85M Perf Year-44.57%
Cash/sh1.36 P/C12.23 EPS next 5Y- ROE43.93% 52W Range6.46 - 30.07 Perf YTD-2.81%
Dividend Est.- P/FCF126.50 EPS past 5Y- ROI15.24% 52W High-44.79% Beta2.30
Dividend TTM- Quick Ratio2.84 Sales past 5Y2506.46% Gross Margin93.40% 52W Low156.97% ATR (14)0.81
Dividend Ex-Date- Current Ratio3.62 EPS Y/Y TTM123.31% Oper. Margin16.71% RSI (14)55.44 Volatility3.85% 5.42%
Employees264 Debt/Eq0.70 Sales Y/Y TTM3275.73% Profit Margin14.24% Recom1.56 Target Price31.50
Option/ShortYes / Yes LT Debt/Eq0.69 EPS Q/Q73.82% Payout0.00% Rel Volume0.38 Prev Close16.48
Sales Surprise16.25% EPS Surprise-16.67% Sales Q/Q713.46% EarningsMay 01 BMO Avg Volume3.74M Price16.60
SMA204.14% SMA508.38% SMA20024.94% Trades Volume1,438,394 Change0.73%
Date Action Analyst Rating Change Price Target Change
Aug-02-23Upgrade Goldman Sell → Neutral $16 → $12
Jun-26-23Resumed Jefferies Buy $55 → $40
May-20-22Initiated BofA Securities Underperform $5
Feb-23-22Reiterated B. Riley Securities Buy $49 → $35
Nov-15-21Downgrade Goldman Neutral → Sell $33 → $26
Apr-20-21Initiated Goldman Neutral $50
Apr-19-21Reiterated H.C. Wainwright Buy $79 → $89
Sep-01-20Initiated JP Morgan Overweight $38
Aug-11-20Reiterated H.C. Wainwright Buy $32 → $38
Jun-05-20Initiated Evercore ISI Outperform $60
May-03-24 09:33AM
05:56AM
May-02-24 03:05AM
12:27AM
May-01-24 11:53AM
08:34AM Loading…
08:34AM
08:30AM
07:32AM
07:00AM
Apr-30-24 04:55PM
09:35AM
Apr-27-24 09:37AM
Apr-18-24 07:30AM
07:00AM
Apr-15-24 07:30AM
07:07AM Loading…
Mar-13-24 07:07AM
Mar-08-24 07:30AM
Mar-01-24 07:30AM
Feb-29-24 09:22AM
Feb-28-24 10:24PM
04:05PM
08:10AM
07:52AM
07:21AM
07:00AM
Feb-27-24 07:30AM
Feb-26-24 07:00AM
Feb-23-24 07:30AM
Feb-20-24 10:00AM
07:30AM
07:20AM Loading…
Feb-13-24 07:20AM
Jan-22-24 06:30AM
Jan-10-24 04:09PM
09:33AM
07:00AM
Jan-09-24 09:03AM
07:00AM
Jan-06-24 05:02AM
Jan-05-24 07:30AM
Dec-15-23 10:22AM
Dec-07-23 03:31PM
Nov-27-23 07:30AM
Nov-06-23 09:55AM
09:27AM
Nov-03-23 07:30AM
Nov-01-23 12:18PM
10:21AM
09:17AM
07:43AM
07:30AM
Oct-30-23 07:30AM
Oct-14-23 01:15PM
Oct-12-23 11:00AM
Oct-11-23 10:30AM
Oct-06-23 08:30AM
Oct-02-23 07:30AM
Sep-28-23 10:17AM
Sep-22-23 07:30AM
Sep-07-23 07:30AM
Sep-06-23 01:06PM
Aug-29-23 12:43AM
Aug-19-23 11:22AM
Aug-12-23 11:05AM
Aug-04-23 06:20AM
Aug-03-23 06:10AM
Aug-01-23 04:04PM
02:28PM
11:50AM
08:35AM
07:28AM
07:15AM
07:00AM
Jul-31-23 08:30AM
Jul-25-23 11:46AM
10:57AM
Jul-24-23 09:35AM
Jul-21-23 12:30PM
Jul-13-23 04:05PM
Jul-10-23 02:01AM
Jul-03-23 09:00AM
Jul-01-23 09:00AM
Jun-27-23 09:22AM
06:46AM
Jun-08-23 08:30AM
Jun-06-23 01:13PM
Jun-05-23 07:30AM
Jun-02-23 09:15AM
Jun-01-23 09:15AM
May-31-23 07:30AM
May-18-23 11:05AM
May-04-23 10:16AM
07:30AM
May-01-23 10:32PM
04:28PM
04:03PM
08:45AM
07:30AM
Apr-28-23 04:30PM
Apr-27-23 07:30AM
Apr-25-23 08:45AM
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lonial SagarDirectorMar 13 '24Sale15.945,00079,675108,878Mar 15 04:37 PM
Charney Laurence NDirectorMar 12 '24Sale15.9722,000351,340215,229Mar 13 04:52 PM
Charney Laurence NDirectorJan 05 '24Sale19.0317,500333,025237,229Jan 08 06:33 PM
Power Sean ACFOJan 03 '24Sale16.9147,867809,431606,969Jan 05 05:00 PM
WEISS MICHAEL SCEO and PresidentAug 11 '23Buy10.13100,0001,013,00012,073,021Aug 14 09:54 AM
Lonial SagarDirectorJun 23 '23Sale23.3734,854814,53893,878Jun 26 05:00 PM
Power Sean AChief Financial OfficerJun 02 '23Sale26.7073,6471,966,375654,836Jun 05 06:26 PM